Literature DB >> 11485534

Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma.

A Machens1, R Hinze, C Lautenschläger, H Dralle.   

Abstract

HYPOTHESIS: Insular carcinoma represents a more aggressive subtype of differentiated thyroid cancer on multivariate analysis after controlling for various clinicopathologic parameters.
DESIGN: Retrospective analysis.
SETTING: Tertiary referral center at a university hospital. PATIENTS: One hundred twenty-seven consecutive patients having a histological diagnosis of the follicular variant of papillary thyroid carcinoma or follicular thyroid carcinoma. MAIN OUTCOME MEASURE: A logistic regression model was used to examine the relationship between various clinicopathologic parameters and the insular subtype.
RESULTS: The insular subtype involved 14 of 127 tumors. Unlike extrathyroidal extension and nodal metastasis, primary tumor diameter (> 40 mm vs < or = 40 mm; P = .008) and distant metastasis (P = .003) correlated with the insular subtype. Both parameters were interrelated since tumors greater than 40 mm displayed distant metastasis more often (30% vs 8%; P = .008) than tumors measuring 40 mm or less.
CONCLUSIONS: These findings suggest that an unidentified somatic event may induce an accelerated proliferation of the transformed thyrocytes, which may ultimately result in enhanced rates of distant metastasis with increasing tumor volume.

Entities:  

Mesh:

Year:  2001        PMID: 11485534     DOI: 10.1001/archsurg.136.8.941

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas.

Authors:  Ayman Agha; Gabriel Glockzin; Matthias Woenckhaus; Wolfgang Dietmaier; Igors Iesalnieks; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2007-01-10       Impact factor: 3.445

2.  Follicular thyroid carcinoma presenting as a massive chest wall tumor.

Authors:  Ryan Gertz; Rakesh Sarda; Ricardo Lloyd
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 3.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

4.  Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course.

Authors:  Tzu-Chieh Chao; Jen-Der Lin; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

5.  Insular thyroid carcinoma in a Filipino woman.

Authors:  Mark Anthony S Sandoval; Elizabeth Paz-Pacheco
Journal:  BMJ Case Rep       Date:  2010-11-18

6.  The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors.

Authors:  Andreas Machens; Hans-Jürgen Holzhausen; Christine Lautenschläger; Henning Dralle
Journal:  Langenbecks Arch Surg       Date:  2004-05-25       Impact factor: 3.445

7.  Significance of an insular component in follicular thyroid carcinoma with distant metastasis at initial presentation.

Authors:  Hiroto Yamashita; Yasushi Noguchi; Shiro Noguchi; Hiroyuki Yamashita; Shinya Uchino; Shinn Watanabe; Takahiro Ogawa; Tsukasa Murakami
Journal:  Endocr Pathol       Date:  2005       Impact factor: 4.056

8.  Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database.

Authors:  Yan Liu; Zeming Liu; Qiuyang Zhao; Teng Hua; Shuqi Chi; Tao Huang; Hongbo Wang
Journal:  Oncotarget       Date:  2017-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.